MethylGene is a publicly-traded biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics in cancer and infectious diseases. We intend to exploit our HDAC inhibitor technology in other diseases, such as ...
If you would like to receive any additional information regarding our prices, services and product description you can address your inquiry and we will contact you as soon as possible. Please, fill out this form: